Señales en vivo de RSLS | Maximiza tus Ganancias con Getagraph.com

COMPRAR 130541 min ago

@ $0.190

Emitido: 6 feb 2024 @ 11:13

Retorno: -11.95%

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 16:00):

Stats
Volumen de hoy	99 491.00
Volumen promedio	487 631
Capitalización de mercado	3.92M
EPS	$-0.110 ( 2024-04-15 )
Próxima fecha de ganancias	( $-0.160 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$0.00100 (0.60%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-05	Schneid Yair	Sell	0	Common Stock
2023-08-04	Stankovich Thomas	Sell	108	Common Stock, $0.001 par value per share
2023-08-24	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share
2023-09-01	Stankovich Thomas	Sell	118	Common Stock, $0.001 par value per share
2023-10-11	Stankovich Thomas	Sell	39	Common Stock, $0.001 par value per share

INSIDER POWER
-2.76
Last 95 transactions
Buy: 10 386 223 \| Sell: 2 711 639

Volumen Correlación

Largo: 0.10 (neutral)

Corto: -0.75 (moderate negative)

Signal:(47.614) Neutral

ReShape Lifesciences Inc Correlación

10 Correlaciones Más Positivas
LGVN	0.931
PAIC	0.919
CNSP	0.911
HJLIW	0.908
AXDX	0.903
PCSA	0.902
AGRI	0.901
KXIN	0.901
DXYN	0.901
EBIX	0.898

10 Correlaciones Más Negativas
NETE	-0.922
BRIVU	-0.914
AMRB	-0.906
STAY	-0.901
NVCN	-0.899
SILK	-0.897
MSDA	-0.896
CGEM	-0.895
RAVN	-0.893
TIOA	-0.89

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ReShape Lifesciences Inc Correlación - Moneda/Commodity

-0.56
( weak negative )

-0.63
( weak negative )

0.00
( neutral )

0.28
( neutral )

ReShape Lifesciences Inc Finanzas

Annual	2023
Ingresos:	$8.68M
Beneficio Bruto:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2023
Ingresos:	$8.68M
Beneficio Bruto:	$5.55M (63.93 %)
EPS:	$-1.910

FY	2022
Ingresos:	$11.24M
Beneficio Bruto:	$6.80M (60.52 %)
EPS:	$-108.90

FY	2021
Ingresos:	$13.60M
Beneficio Bruto:	$8.35M (61.38 %)
EPS:	$-250.16

Financial Reports:

No articles found.

ReShape Lifesciences Inc

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.